Produkty 521-03-9

CAS 521-03-9 występuje w naszej ofercie pod nazwami: Stigmastanol Impurity 1, delta(7)-Stigmastenol, 22,23-Dihydrospinasterol, >95% (HPLC), Schottenol. Oferty producentów: Chemat Brand, TRC, MedChemExpress. Dostępne opakowania: on request, 25mg, 50mg, 5mg, 5 mg.

Stigmastanol Impurity 1
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
delta(7)-Stigmastenol
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
22,23-Dihydrospinasterol, >95% (HPLC)
TRC
  • opakowanie: 25mg, 50mg, 5mg
  • Warianty: 3
Zobacz produkt
Schottenol
MedChemExpress
  • opakowanie: 5 mg
  • Warianty: 1
od 2469,86
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,5S,9R,10S,13R,14R,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol (CAS 521-03-9) to związek chemiczny o wzorze sumarycznym C29H50O i masie molowej 414.7 g/mol. Nazwa systematyczna IUPAC: (3S,5S,9R,10S,13R,14R,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol. InChIKey: YSKVBPGQYRAUQO-UZSYLJJSSA-N.

Dane identyfikacyjne
Wzór sumarycznyC29H50O
Masa molowa414.7 g/mol
Nazwa IUPAC(3S,5S,9R,10S,13R,14R,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
InChIKeyYSKVBPGQYRAUQO-UZSYLJJSSA-N
SMILESCC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C)C(C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Schottenol, 7-Sitoster-3beta-ol, 16,17,25,26-Tetrahydroelasterol, 24alpha-Ethyllathosterol, delta7-Stigmasten-3beta-ol, 24alpha-Ethyl-delta7-cholestenol, Stigmast-7-en-3-ol, (3beta)-, 24-Ethyl-cholesta-7-en-3beta-ol, 24-Ethyl-5alpha-cholest-7-ene-3beta-ol, Stigmast-7-en-3-ol, (3I2,5I+-)-
Izomery (ten sam wzór sumaryczny)
(3S,8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol C29H50O
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C29H50O
(3S,5R,10S,13R,14R,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,7,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol C29H50O
(8S,9S,10R,13R,14S,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-2,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one C29H50O